Skip to main content

Table 1 Characteristics of CRC patients

From: Colorectal cancer cell-derived CCL20 recruits regulatory T cells to promote chemoresistance via FOXO1/CEBPB/NF-κB signaling

Characteristics CRC patients with traditional Folfox CRC patients with neoadjuvant Folfox CRC patients without Folfox
Number % Number % Number %
Gender
 Male 46 52.8 31 56.4 51 49.0
 Female 41 47.1 24 23.1 53 51.0
Age (years)
  < 60 44 50.6 29 52.7 57 54.8
  ≥ 60 43 49.4 26 47.3 47 45.2
Location
 Colon 56 64.4 36 65.5 61 58.7
 Rectum 31 35.6 19 34.5 43 41.3
Tumor size
  < 40 mm 50 57.5 33 60.0 60 57.7
  ≥ 40 mm 37 42.5 22 40.0 44 42.3
Pathological type
 Adenocarcinoma 77 88.5 45 81.8 94 90.3
 Others 10 11.5 10 18.2 10 9.6
Lymph node metastasis
 Yes 41 47.1 25 45.5 53 51.0
 No 46 52.9 30 54.5 51 49.0
Distant metastasis
 Yes 34 39.1 27 49.0 23 22.1
 No 53 60.9 28 50.9 81 77.9
TNM Stage
 I 5 5.7 5 9.0 12 11.5
 II 36 41.4 18 32.7 39 37.5
 III 25 28.7 6 10.9 30 28.8
 IV 21 24.1 27 49.0 23 22.1
Differentiation
 Low 5 5.7 7 12.7 6 5.7
 Low-moderate 15 17.2 10 18.2 18 17.3
 Moderate 67 77.0 38 69.1 80 74.8